" class="no-js "lang="en-US"> Colin McCracken - Medtech Alert
Sunday, June 22, 2025
Colin McCracken

Colin McCracken

About Colin McCracken

COlin joined Evonetix in June 2022 and brings over 20 years’ experience in commercial and business development roles. Prior to joining Evonetix he was Senior Vice President and Chief Commercial Officer at Fluidigm Corp, where he was responsible for leading all commercial activities, driving revenue growth, and expanding the Company’s global reach. He has delivered commercial success in numerous leadership positions, including Vice President and General Manager and Vice President of Sales at Thermo Fisher Scientific, Vice President and Head of European Sales at Life Technologies and National Sales Manager at Qiagen.

As CEO of Evonetix, Colin will focus on building strategic partnerships and customer relationships, ahead of the commercial introduction of the Company’s first benchtop DNA printer.

Related Story

Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on Its Semiconductor Chip

August 17 2022

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]

Evonetix Appoints Colin McCracken as Chief Executive Officer

June 14 2022

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the […]